PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32955957-6	2021	After 12 months, rosuvastatin produced a significant decrease in mean serum levels of hsCRP (-0.28 mg/dL; p = .037), IL-6 (-2.1 pg/mL; p = .018) and TNF-alpha (-6.3 pg/mL; p = .004) in patients with MetS.	Rosuvastatin Calcium	17-29	tumor necrosis factor	Homo sapiens	149-158